Ceylon Hospitals PLC (COSE:CHL.X0000)
Sri Lanka · Delayed Price · Currency is LKR 124.25
+7.25 (6.20%)
At close: Jul 24, 2025
Ceylon Hospitals Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 9,744 | 9,153 | 7,905 | 7,841 | 5,546 | Upgrade | |
Revenue Growth (YoY) | 6.46% | 15.78% | 0.82% | 41.39% | -7.20% | Upgrade |
Cost of Revenue | 3,914 | 4,014 | 3,095 | 2,880 | 2,052 | Upgrade |
Gross Profit | 5,830 | 5,139 | 4,811 | 4,961 | 3,494 | Upgrade |
Selling, General & Admin | 3,720 | 3,302 | 2,878 | 2,854 | 2,337 | Upgrade |
Other Operating Expenses | 1,150 | 1,254 | 1,020 | 717.5 | 521.87 | Upgrade |
Operating Expenses | 4,870 | 4,556 | 3,898 | 3,571 | 2,859 | Upgrade |
Operating Income | 960.5 | 582.91 | 913.18 | 1,389 | 634.5 | Upgrade |
Interest Expense | -252.76 | -144.05 | -83.35 | -76.56 | -93.01 | Upgrade |
Interest & Investment Income | 242.84 | 99.66 | 207.25 | 81.82 | 50.31 | Upgrade |
Earnings From Equity Investments | - | - | - | 11.72 | 102.87 | Upgrade |
Other Non Operating Income (Expenses) | -0 | -0.62 | -4.54 | -4.01 | -3.67 | Upgrade |
EBT Excluding Unusual Items | 950.58 | 537.9 | 1,033 | 1,402 | 691 | Upgrade |
Gain (Loss) on Sale of Investments | - | 113.44 | 27.8 | -32.92 | - | Upgrade |
Gain (Loss) on Sale of Assets | - | 6.43 | - | 5.2 | 5.34 | Upgrade |
Other Unusual Items | - | 1.11 | - | 14.45 | - | Upgrade |
Pretax Income | 950.58 | 658.89 | 1,060 | 1,389 | 696.34 | Upgrade |
Income Tax Expense | 201.49 | 205.07 | 408.65 | 279.38 | 96.08 | Upgrade |
Earnings From Continuing Operations | 749.09 | 453.81 | 651.67 | 1,110 | 600.26 | Upgrade |
Minority Interest in Earnings | -85.55 | -36.62 | -79.84 | -127.2 | -39.91 | Upgrade |
Net Income | 663.54 | 417.19 | 571.83 | 982.32 | 560.35 | Upgrade |
Net Income to Common | 663.54 | 417.19 | 571.83 | 982.32 | 560.35 | Upgrade |
Net Income Growth | 59.05% | -27.04% | -41.79% | 75.31% | 38.95% | Upgrade |
Shares Outstanding (Basic) | 42 | 36 | 34 | 34 | 34 | Upgrade |
Shares Outstanding (Diluted) | 42 | 36 | 34 | 34 | 34 | Upgrade |
Shares Change (YoY) | 16.39% | 6.23% | 0.02% | - | - | Upgrade |
EPS (Basic) | 15.84 | 11.59 | 16.88 | 29.00 | 16.54 | Upgrade |
EPS (Diluted) | 15.84 | 11.59 | 16.88 | 29.00 | 16.54 | Upgrade |
EPS Growth | 36.65% | -31.32% | -41.80% | 75.31% | 38.95% | Upgrade |
Free Cash Flow | 657.64 | -60.01 | -2,110 | 395.27 | 879.95 | Upgrade |
Free Cash Flow Per Share | 15.70 | -1.67 | -62.29 | 11.67 | 25.98 | Upgrade |
Dividend Per Share | 4.000 | 2.000 | 2.300 | 5.000 | 3.200 | Upgrade |
Dividend Growth | 100.00% | -13.04% | -54.00% | 56.25% | 45.45% | Upgrade |
Gross Margin | 59.84% | 56.14% | 60.86% | 63.27% | 63.00% | Upgrade |
Operating Margin | 9.86% | 6.37% | 11.55% | 17.72% | 11.44% | Upgrade |
Profit Margin | 6.81% | 4.56% | 7.23% | 12.53% | 10.11% | Upgrade |
Free Cash Flow Margin | 6.75% | -0.66% | -26.70% | 5.04% | 15.87% | Upgrade |
EBITDA | 1,529 | 1,025 | 1,302 | 1,729 | 989.24 | Upgrade |
EBITDA Margin | 15.70% | 11.20% | 16.48% | 22.05% | 17.84% | Upgrade |
D&A For EBITDA | 568.97 | 442.58 | 389.26 | 339.85 | 354.74 | Upgrade |
EBIT | 960.5 | 582.91 | 913.18 | 1,389 | 634.5 | Upgrade |
EBIT Margin | 9.86% | 6.37% | 11.55% | 17.72% | 11.44% | Upgrade |
Effective Tax Rate | 21.20% | 31.12% | 38.54% | 20.11% | 13.80% | Upgrade |
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.